052006

VEGF, Bevacizumab Biosimilar

Größe

£576.00

SKU:: 052006
Reinheit:: Purified by Protein A/G affinity chromatography. Endotoxin: ≤0.75EU/mg (LAL)
Lagerbedingungen:: -20°C
Hersteller:: United States Biological
Host:: Human
Immunogen:: Recombinant protein corresponding to human VEGF, expressed in CHO cells.
Format:: Supplied as a sterile, clear or slightly milky white, colorless to light brown liquid, containing trehalose, monobasic sodium phosphate monohydrate, sodium dihydrogen phosphate and Tween 20. pH 6.2. BSA and Azide free.
Weitere Details:: Bevacizumab is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Bevacizumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary). Applications: Suitable for use in Functional Assays. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.